Status:
RECRUITING
Combined Lactulose H2-breath Test With Abdominal Imaging
Lead Sponsor:
Klinik Arlesheim
Collaborating Sponsors:
Kantonsspital Baselland Bruderholz
Conditions:
Food Intolerance Syndromes
Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Eligibility:
All Genders
18+ years
Brief Summary
Hydrogen (H₂) breath tests serve several purposes. (i) detect malabsorption of carbohydrates such as lactose and fructose, (ii) measurement of oro-caecal transit time (iii) associate hydrogen producti...
Detailed Description
Carbohydrate malabsorption can be detected by hydrogen (H2) breath tests because this gas is not generated by human cells but is derived exclusively through anaerobic fermentation of carbohydrates by ...
Eligibility Criteria
Inclusion
- Patients referred for breath testing to assess the causes of digestive symptoms or maldigestion 2020-2024
- Patients signed general consent to allow use of clinical data obtained during clinical assessment and breath testing to be used in research project.
Exclusion
- \-
Key Trial Info
Start Date :
August 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07145580
Start Date
August 1 2025
End Date
December 31 2026
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik Arlesheim
Arlesheim, Basel-Landschaft, Switzerland, 4144